Number of Participants With Recurrent Symptomatic Venous Thromboembolism (VTE) and Deaths Related to VTE For statistical analysis 1: from randomisation to end of post treatment period (ptp), planned to be up to day 224. For statistical analysis 2: from randomisation to 6 months (up to day 180) [clinicaltrials_resource:d75ec99eeae1630e620c07a56964a7bb]
All suspected recurrent VTEs and all deaths and bleeding events were evaluated by an independent central adjudication committee, and all analyses are based on the events that were centrally confirmed by this committee.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants With Recurrent Symptomatic Venous Thromboembolism (VTE) and Deaths Related to VTE For statistical analysis 1: from randomisation to end of post treatment period (ptp), planned to be up to day 224. For statistical analysis 2: from randomisation to 6 months (up to day 180) [clinicaltrials_resource:d75ec99eeae1630e620c07a56964a7bb]
All suspected recurrent VTEs and all deaths and bleeding events were evaluated by an independent central adjudication committee, and all analyses are based on the events that were centrally confirmed by this committee.
Bio2RDF identifier
d75ec99eeae1630e620c07a56964a7bb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d75ec99eeae1630e620c07a56964a7bb
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Re ...... VTE) and Deaths Related to VTE
time frame [clinicaltrials_vocabulary:time-frame]
For statistical analysis 1: fr ...... on to 6 months (up to day 180)
description
All suspected recurrent VTEs a ...... y confirmed by this committee.
identifier
clinicaltrials_resource:d75ec99eeae1630e620c07a56964a7bb
title
Number of Participants With Re ...... on to 6 months (up to day 180)
@en
type
label
Number of Participants With Re ...... ec99eeae1630e620c07a56964a7bb]
@en